Clinical Trail-Based Economic Analyses

Clinical-Trial Based Economic Analyses

Our clients understand the need to develop a health economic strategy early in development of new products. We help our clients incorporate health economic endpoints into clinical trials so that they are able to demonstrate the economic value of their drugs to HTA authorities, payers, physicians, patients and other stakeholders. Additionally, we provide health economic analysis of data from clinical trials and collaborate with clients on manuscripts and other reports.

SENIOR LEADERSHIP

Stephen M Beard, MSc
Global Head of Health Economics, Europe

Stephanie R Earnshaw, PhD
Vice President, US Health Economics

Josephine A Mauskopf, PhD
Vice President, Health Economics

For a full list of scientific staff bios, click here.

DOWNLOADS

Fact Sheets

-	Health Economics
-	Database Analysis
-	Pricing and Reimbursement
-	Product Value Dossiers
-	Health Preference Assessment
-	Patient-Reported Outcomes

To learn more about our research and consulting services, please call us at:

US: +1.800.262.3011
Spain: +34.93.241.7766
UK: +44(0)161.232.3400

Or email one of our experts directly.